- Home
- VRDN vs EVLV Comparison
VRDN vs EVLV Comparison
Compare VRDN & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- EVLV
- Stock Information
- Founded
- VRDN 2006
- EVLV 2013
- Country
- VRDN United States
- EVLV United States
- Employees
- VRDN N/A
- EVLV N/A
- Industry
- VRDN Medical Specialities
- EVLV Computer peripheral equipment
- Sector
- VRDN Health Care
- EVLV Technology
- Exchange
- VRDN Nasdaq
- EVLV Nasdaq
- Market Cap
- VRDN 1.3B
- EVLV 1.2B
- IPO Year
- VRDN N/A
- EVLV N/A
- Fundamental
- Price
- VRDN $18.54
- EVLV $7.75
- Analyst Decision
- VRDN Strong Buy
- EVLV Strong Buy
- Analyst Count
- VRDN 11
- EVLV 4
- Target Price
- VRDN $38.80
- EVLV $8.88
- AVG Volume (30 Days)
- VRDN 767.6K
- EVLV 3.4M
- Earning Date
- VRDN 08-06-2025
- EVLV 08-14-2025
- Dividend Yield
- VRDN N/A
- EVLV N/A
- EPS Growth
- VRDN N/A
- EVLV N/A
- EPS
- VRDN N/A
- EVLV N/A
- Revenue
- VRDN $305,000.00
- EVLV $121,011,000.00
- Revenue This Year
- VRDN N/A
- EVLV $26.46
- Revenue Next Year
- VRDN $17,102.33
- EVLV $18.80
- P/E Ratio
- VRDN N/A
- EVLV N/A
- Revenue Growth
- VRDN 5.90
- EVLV 36.64
- 52 Week Low
- VRDN $9.90
- EVLV $2.04
- 52 Week High
- VRDN $27.20
- EVLV $8.91
- Technical
- Relative Strength Index (RSI)
- VRDN 62.06
- EVLV 73.12
- Support Level
- VRDN $15.68
- EVLV $7.10
- Resistance Level
- VRDN $19.10
- EVLV $7.57
- Average True Range (ATR)
- VRDN 1.01
- EVLV 0.40
- MACD
- VRDN 0.08
- EVLV 0.04
- Stochastic Oscillator
- VRDN 83.63
- EVLV 55.43
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About EVLV Evolv Technologies Holdings Inc.
Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.